Opendata, web and dolomites

HUMANeye SIGNED

Implantable titanium net to combat pathological corneal shape deformations

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HUMANeye project word cloud

Explore the words cloud of the HUMANeye project. It provides you a very rough idea of what is the project "HUMANeye" about.

external    profits    indirect    correction    visual    halts    rates    commercial    gives    centres    direct    successfully    disease    adults    net    refractive    2050    quality    young    worth    tissue    dome    errors    smes    14k    revenues    compromised    matches    internal    surgery    entire    care    6m    2019    grade    medical    multiple    patient    cornea    manufacture    healthcare    progression    predicted    corrects    necessitating    cumulative    66    error    transplantation    1bn    natural    life    world    global    withstand    breakthrough    uniquely    ophthalmic    laser    9m    unites    save    ring    70    layers    disability    aggressive    limited    pathological    938k    population    implanted    reproducible    corneal    295k    21    clinic    tend    license    operations    considerably    reductive    reducing    titanium    spiraling    fashioned    shaped    sme    options    chain    unpredictable    2023    deep    rollout    implantation    severely    hi    patients    productivity    push    implants    tech    until    treatment    shape    humaneye    market    generate    2027    pcsd    10    architecture    severe    deformations    prove    trillion    54    48    potently    employment    stronger    103    public    launch    jobs   

Project "HUMANeye" data sheet

The following table provides information about the project.

Coordinator
FUNDACIO DE RECERCA DEL INSTITUT DE MICROCIRURGIA OCULAR 

Organization address
address: CARRER JOSEP MARIA LLADO, 3
city: Barcelona
postcode: 8024
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 1˙997˙847 €
 EC max contribution 1˙632˙797 € (82%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-EIC-FTI-2018-2020
 Funding Scheme IA
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2022-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FUNDACIO DE RECERCA DEL INSTITUT DE MICROCIRURGIA OCULAR ES (Barcelona) coordinator 541˙037.00
2    RECORNEA SRL IT (MARTIGNACCO UD) participant 553˙401.00
3    BLUEACRE TECHNOLOGY LIMITED IE (DUNDALK) participant 298˙379.00
4    CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE FR (TOULOUSE CEDEX 3) participant 239˙980.00

Map

 Project objective

The global costs from visual refractive errors will reach some €1.2 trillion in 2019. This type of disability is on the increase and it is predicted that it will affect 10% of the World population by 2050. Pathological corneal shape deformations (PCSD) are a common cause of severe refractive error that tend to occur in young adults, considerably reducing both their quality of life and work productivity. Current treatment options are severely limited. The compromised cornea cannot withstand aggressive reductive laser surgery. Corneal transplantation gives highly unpredictable results, necessitating multiple operations that lead to spiraling treatment costs of over €14k per patient.

HUMANEYE is a breakthrough dome-shaped corneal net fashioned in medical-grade titanium. Implanted deep within the cornea, it potently corrects refractive error and halts disease progression in PCSD. It uniquely matches the natural architecture of tissue layers throughout the entire tissue, leading to simple reproducible implantation, 70% higher success rates and 66% stronger refractive correction than current ring-shaped implants on the market today.

The HUMANeye project unites two hi-tech SMEs, to manufacture the technology and push it to market, with two leading European ophthalmic care centres to prove its worth in the clinic. From HUMANEYE launch in 2023 until 2027, our SME partners will together generate €103.6m in cumulative revenues and €54.9m in profits. Rollout with an established commercial license partner will generate 21 internal and 48 external jobs in our value chain. 938k successfully operations will help 295k patients to better employment and save €20.1bn in direct public healthcare and indirect productivity costs.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HUMANEYE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HUMANEYE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.1.)

GoSafe (2019)

Restoring complete sensory ability for natural walking of amputees

Read More  

BIOSNAP (2019)

SMART, SUSTAINABLE & CONVENIENT UNIT DOSE PACKAGING

Read More  

Mag-ID (2019)

Magnetic identification

Read More